Epigral's Q3 FY26 results were weak, with EBITDA margin contracting to 17% (vs 22% 9M average) due to lower realizations, higher raw material costs, and high-cost inventory.
✓ Verified against BSE filing
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Reliance and Adani are expanding PVC/CPVC capacity, and other players may backward integrate, potentially leading to pricing pressure and lower utilization for Epigral's new capacities.
high · analyst_questionThe chlorotoluene plant is still in early stages with customer approvals and long-term contracts not yet secured; meaningful contribution may be delayed beyond FY27.
medium · management_commentaryQ3 margins were hit by high-cost inventory and falling PVC prices; if raw material prices rise again without corresponding product price increases, margins could remain under pressure.
medium · data_observationUS-India trade tensions, tariff impacts, and global geopolitical issues could affect export volumes and realizations, especially for ECH and other specialty chemicals.
medium · management_commentary